vTv Therapeutics Inc. (VTVT) Institutional Ownership

Ownership Summary

vTv Therapeutics Inc. (NASDAQ:VTVT) currently has 23 active institutional owners and shareholders as of today (September 2025), that have filed 13F forms with the Securities Exchange Commission (SEC).

• The percentage of vTv Therapeutics owned by institutions changed from 18.4% in June 2025 to 30.9% in September 2025, marking a slight up trend.
• In percentage terms, this reflects as a holdings change of 68.27% quarter on quarter, and an increase of 15.00% year over year.
• The latest 13F cycle for vTv Therapeutics reveals that of 23 total investors, 10 funds grew their exposure, whereas 3 reduced theirs and 10 made no changes.
• Collectively, institutional investors increased their stake in vTv Therapeutics to 988.28K shares as of September 2025, a change that is up by 400.96K shares quarter on quarter and up 445.95K shares year over year.
• As of September 30, 2025, Samsara BioCapital, LLC held vTv Therapeutics's largest shareholding position with over 374.46K shares, representing 11.72% of total outstanding shares.
• Among the most significant buyers of vTv Therapeutics during September 2025 were Samsara BioCapital, LLC (167.68K), Siren, L.L.C. (163.00K), BAKER BROS. ADVISORS LP (51.00K), FMR LLC (14.69K), VANGUARD GROUP INC (3.81K).
• Leading sellers of vTv Therapeutics stock in September 2025 included MILLENNIUM MANAGEMENT LLC (2.11K), NORTHERN TRUST CORP (1.22K), BANK OF AMERICA CORP /DE/ (11).
• The top 10 institutional holders of vTv Therapeutics for the quarter ending September 2025 included Samsara BioCapital, LLC (374.46K), FMR LLC (192.89K), Siren, L.L.C. (163.00K), BAKER BROS. ADVISORS LP (148.31K), VANGUARD GROUP INC (46.99K), GEODE CAPITAL MANAGEMENT, LLC (15.30K), NORTHERN TRUST CORP (14.07K), MILLENNIUM MANAGEMENT LLC (12.94K), Connective Capital Management, LLC (9.71K), BlackRock, Inc. (4.93K).